Anna Beth Parlier-Ahmad, Lillia Thumma, Sarah Martin, Michelle Eglovitch, Kameron Simmons, Tiffany Kimbrough, Dace S Svikis, Caitlin E Martin
{"title":"Feasibility trial of a technology-delivered intervention for opioid use disorder recovery postpartum.","authors":"Anna Beth Parlier-Ahmad, Lillia Thumma, Sarah Martin, Michelle Eglovitch, Kameron Simmons, Tiffany Kimbrough, Dace S Svikis, Caitlin E Martin","doi":"10.1080/1067828x.2024.2447774","DOIUrl":null,"url":null,"abstract":"<p><p>This randomized feasibility trial aimed to 1) assess methodology for a subsequent efficacy trial and 2) examine the usability and acceptability of Project BETTER's hybrid technology-delivered educational intervention for pregnant people receiving medication for opioid use disorder within a perinatal addiction treatment clinic. Participants were randomized to the technology-delivered educational intervention or standard practice control (brochure). Project BETTER's intervention offers three modules (pregnancy-to-postpartum transition, Neonatal Opioid Withdrawal Syndrome, child welfare interactions) via Computerized Intervention Authoring System (CIAS 3.0). Inclusion criteria were: ≥18 years of age, <34 weeks pregnant, currently receiving medication for opioid use disorder (MOUD), and had engaged in care ≤10 weeks during their current pregnancy. Study visits included an online survey, brief interview, and medical record review. Mean perceived helpfulness scores were compared by study condition using independent samples t-test. The screening process identified 49 potential participants, n=31 (63%) of whom were recruited. Twenty-nine participants were randomized (intervention: n=16, control: n=13). Participants (n=29) were reproductive age [M = 30.0 years (SD = 4.4)], 66% white and 31% Black with a median estimated gestational age of 24 weeks. Most participants (69%) received buprenorphine. Study completion rate was 83%. Most participants completed study components remotely. Among participants in the intervention group, 56% completed at least one module. Participants perceived the intervention to be as helpful as the brochure (intervention: 5.28 ± 0.98, control: 5.39 ± 0.56, p=0.387) and highly acceptable. With protocol modifications, scale up to a larger clinical trial is feasible and acceptable to pregnant people receiving MOUD.</p>","PeriodicalId":46463,"journal":{"name":"JOURNAL OF CHILD & ADOLESCENT SUBSTANCE ABUSE","volume":"30 2","pages":"52-63"},"PeriodicalIF":0.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12338197/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOURNAL OF CHILD & ADOLESCENT SUBSTANCE ABUSE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/1067828x.2024.2447774","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Social Sciences","Score":null,"Total":0}
引用次数: 0
Abstract
This randomized feasibility trial aimed to 1) assess methodology for a subsequent efficacy trial and 2) examine the usability and acceptability of Project BETTER's hybrid technology-delivered educational intervention for pregnant people receiving medication for opioid use disorder within a perinatal addiction treatment clinic. Participants were randomized to the technology-delivered educational intervention or standard practice control (brochure). Project BETTER's intervention offers three modules (pregnancy-to-postpartum transition, Neonatal Opioid Withdrawal Syndrome, child welfare interactions) via Computerized Intervention Authoring System (CIAS 3.0). Inclusion criteria were: ≥18 years of age, <34 weeks pregnant, currently receiving medication for opioid use disorder (MOUD), and had engaged in care ≤10 weeks during their current pregnancy. Study visits included an online survey, brief interview, and medical record review. Mean perceived helpfulness scores were compared by study condition using independent samples t-test. The screening process identified 49 potential participants, n=31 (63%) of whom were recruited. Twenty-nine participants were randomized (intervention: n=16, control: n=13). Participants (n=29) were reproductive age [M = 30.0 years (SD = 4.4)], 66% white and 31% Black with a median estimated gestational age of 24 weeks. Most participants (69%) received buprenorphine. Study completion rate was 83%. Most participants completed study components remotely. Among participants in the intervention group, 56% completed at least one module. Participants perceived the intervention to be as helpful as the brochure (intervention: 5.28 ± 0.98, control: 5.39 ± 0.56, p=0.387) and highly acceptable. With protocol modifications, scale up to a larger clinical trial is feasible and acceptable to pregnant people receiving MOUD.
期刊介绍:
The Journal of Child & Adolescent Substance Abuse addresses the treatment of substance abuse in all ages of children. With the growing magnitude of the problem of substance abuse among children and youth, this is an essential forum for the dissemination of descriptive or investigative efforts with this population. The journal serves as a vehicle for communication and dissemination of information to the many practitioners and researchers working with these young people. With this singular mission in mind, the Journal of Child & Adolescent Substance Abuse provides subscribers with one source for obtaining current, useful information regarding state-of-the-art approaches to the strategies and issues in the assessment, prevention, and treatment of adolescent substance abuse.